MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-05-0002504
Nuthelia Pharmaceuticals Private Limited
Nuthelia Pharmaceuticals Private Limited - electrnoics in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹96.95 Lakh
▲ 16% YoY
Net profit · FY 2025
₹48,115
Net margin 0.5%
EBITDA · FY 2025
₹68,614
EBITDA margin 0.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Nuthelia Pharmaceuticals Private Limited
Data last updated:
Nuthelia Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the repair services segment of the electronics sector. It was incorporated on 19 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52609DL2019PTC353925. Its GSTIN is 09AAGCN6530P1ZV (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anant Kumar Agrawal and Vijay Kumar Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at W/O Sh Tej Pal Sharma E – 103 – A F/F Khno – 162/1 Gali No. 3 Ph – 1 Bhagirathi, Delhi, India – 110094.
As per the financials filed for FY 2025, the company reported a revenue of ₹96.95 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹48,115 (net margin 0.5%) and EBITDA of ₹68,614 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 72% over five years.
Nuthelia Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-05-0002504).
Company details
CIN U52609DL2019PTC353925
Registration Number 353925
Incorporation Date 19 August 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-05-0002504
Recognitions & Rankings of Nuthelia Pharmaceuticals
Contact details
Nuthelia Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressW/O Sh Tej Pal Sharma E – 103 – A F/F Khno – 162/1 Gali No. 3 Ph – 1 Bhagirathi, Delhi, India – 110094
- IndustryElectrnoics, Repair Services
To see the full contact details of Nuthelia Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Nuthelia Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nuthelia Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nuthelia Pharmaceuticals Private Limited, buy the company report.
Financials of Nuthelia Pharmaceuticals Private Limited
FY 2025 filings availableNuthelia Pharmaceuticals Private Limited reported revenue of ₹96.95 Lakh (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹96.95 Lakh ▲ 16%
Net profit · FY 2025
₹48,115 margin 0.5%
EBITDA · FY 2025
₹68,614 margin 0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 45%
5 years · compounded
▲ 72%
EBITDA CAGR growth
1 year
▲ 595%
3 years · compounded
▼ 23%
5 years · compounded
▲ 15%
Revenue has grown at a compounded annual rate (CAGR) of 72% over five years, including 16% growth in the latest year. EBITDA rose 595% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹68,614 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹48,115 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nuthelia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nuthelia Pharmaceuticals Private Limited
Nuthelia Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anant Kumar Agrawal | Director | 19 Aug 2019 | 7 Years 2 Months | Current |
| Vijay Kumar Agrawal | Director | 11 Nov 2022 | 3 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Nuthelia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nuthelia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nuthelia Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCN6530P1ZV | Uttar Pradesh | Active | 29 Sep 2019 |
To see the full GST registrations and return filing status of Nuthelia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nuthelia Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Vijay Kumar Agrawal ceased to be Additional Director on 29 Sep 2023.
AGM
Nuthelia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nuthelia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Vijay Kumar Agrawal ceased to be Additional Director.
Ceased
Ankit Kumar Shrivastava ceased to be Director.
Appointed
Vijay Kumar Agrawal was appointed as Director.
Appointed
Anant Kumar Agrawal was appointed as Director.
Incorporation
19 Aug 2019
Nuthelia Pharmaceuticals Private Limited was registered on 19 Aug 2019 with Roc Delhi & aged 7 years 2 months as per MCA records.
Frequently asked questions
Nuthelia Pharmaceuticals is an active private limited company based in Delhi, India. The company works in repair services, within the electronics industry. It was incorporated on 19 August 2019 (7+ years old) and is registered under CIN U52609DL2019PTC353925.
Nuthelia Pharmaceuticals has 2 current directors:
- Anant Kumar Agrawal - Director
- Vijay Kumar Agrawal - Director
The latest financial statements of Nuthelia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Nuthelia Pharmaceuticals is 09AAGCN6530P1ZV, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Nuthelia Pharmaceuticals is U52609DL2019PTC353925. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nuthelia Pharmaceuticals was incorporated on 19 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Vijay Kumar Agrawal ceased to be Additional Director on 29 Sep 2023. Ankit Kumar Shrivastava ceased to be Director on 11 Nov 2022. Vijay Kumar Agrawal was appointed as Director on 11 Nov 2022. Nuthelia Pharmaceuticals has 4 board changes on record in total.
Yes, Nuthelia Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-05-0002504).
The registered office of Nuthelia Pharmaceuticals is at WO Sh Tej Pal Sharma E – 103 – A FF Khno – 1621 Gali No. 3 Ph – 1 Bhagirathi, Delhi, India – 110094.
Nuthelia Pharmaceuticals operates in the electronics industry, in the repair services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages